Ex Parte HERSH - Page 6


                  Appeal No. 2001-1177                                                           Page 6                    
                  Application No. 08/781,868                                                                               

                  instant claims.  See Pitney Bowes Inc. v. Hewlett Packard Co., 182 F.3d 1298,                            
                  1305, 51 USPQ2d 1161, 1165-66 (Fed. Cir. 1999):  “If . . . the body of the claim                         
                  fully and intrinsically sets forth the complete invention, including all of its                          
                  limitations, and the preamble offers no distinct definition of any of the claimed                        
                  invention’s limitations, but rather merely states, for example, the purpose or                           
                  intended use of the invention, then the preamble is of no significance to claim                          
                  construction.”                                                                                           
                         Appellant has presented no evidence that a composition comprising a                               
                  topical carrier and, e.g., 0.03% glutathione and 0.03% selenomethionine, when                            
                  used to enhance repair of skin following chemosurgery or laser therapy, would                            
                  differ from the same composition when used to protect skin from x-ray induced                            
                  damage.  In this regard, we note that both the patent and the instant application                        
                  disclose exemplary “reparative cream” compositions that contain apparently                               
                  identical ingredients.  See Hersh, column 13, line 50 to column 14, line 26, and                         
                  the instant specification, pages 38-40.                                                                  
                  2.  Anticipation                                                                                         
                         The examiner also rejected all of the instant claims as anticipated by                            
                  Hersh.  The examiner characterized Hersh as disclosing the same compositions                             
                  as are presently claimed, as well as a method of using such compositions to treat                        
                  the skin.  See the Examiner’s Answer, page 4.                                                            
                         “Under 35 U.S.C. § 102, every limitation of a claim must identically appear                       
                  in a single prior art reference for it to anticipate the claim.”  Gechter v. Davidson,                   
                  116 F.3d 1454, 1457, 43 USPQ2d 1030, 1032 (Fed. Cir. 1997).  “[E]very                                    





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007